ApprovalTrail

Approval · Notice of Compliance 2779 · 1998

CILOXAN: Notice of Compliance 2779

Issued June 5, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2779
Date
June 5, 1998
Company
Alcon Canada Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New indication for pediatric use
Therapeutic class
Antibacterial agent

Products in this notice

BrandDINStatus today
CILOXANNot yet assigned—

Medicinal ingredients